Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
USNA
|
Walter Noot
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 1,916 Reduced 37.84% |
$182,748
$95.38 p/Share
|
Feb 11
2021 |
|
BKE
|
Thomas B Heacock
SVP Finance, Treasurer, & CFO |
SELL
Open market or private sale
|
Indirect | 2,600 Reduced 2.6% |
$105,144
$40.44 p/Share
|
Feb 11
2021 |
|
BKE
|
John P Peetz
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.62% |
$20,250
$40.5 p/Share
|
Feb 11
2021 |
|
VIVO
|
John P. Kenny
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,320 Reduced 0.52% |
$39,600
$30.0 p/Share
|
Feb 11
2021 |
|
MNTV
|
Rebecca Cantieri
Chief People Officer |
SELL
Open market or private sale
|
Direct | 9,262 Reduced 8.23% |
$259,336
$28.0 p/Share
|
Feb 11
2021 |
|
MNTV
|
Alexander J Lurie
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 29,608 Reduced 2.9% |
$829,024
$28.0 p/Share
|
Feb 11
2021 |
|
MBUU
|
Wayne R. Wilson
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 14,993 Reduced 19.97% |
$1,169,604
$78.01 p/Share
|
Feb 11
2021 |
|
MBUU
|
Ritchie L. Anderson
President |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 24.99% |
$591,600
$78.88 p/Share
|
Feb 11
2021 |
|
MBUU
|
Jackie D. Springer Jr.
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 17,341 Reduced 21.68% |
$1,338,378
$77.18 p/Share
|
Feb 11
2021 |
|
MBUU
|
Jackie D. Springer Jr.
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 61,888 Reduced 15.54% |
$4,854,495
$78.44 p/Share
|
Feb 11
2021 |
|
SSP
|
Jason Combs
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 493 Reduced 22.24% |
$8,381
$17.0 p/Share
|
Feb 11
2021 |
|
SSP
|
William Appleton |
SELL
Open market or private sale
|
Direct | 509 Reduced 0.41% |
$8,653
$17.0 p/Share
|
Feb 11
2021 |
|
CNOB
|
Michael W Kempner
Director |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 5.83% |
$495,000
$22.5 p/Share
|
Feb 11
2021 |
|
SPH
|
Harold R Logan Jr |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 10.87% |
$45,450
$15.15 p/Share
|
Feb 11
2021 |
|
HLIT
|
Patrick Harshman
President and CEO |
SELL
Open market or private sale
|
Direct | 83,167 Reduced 7.48% |
$649,534
$7.81 p/Share
|
Feb 11
2021 |
|
NPTN
|
Chiyue Cheung
COO |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 100.0% |
$163,410
$12.57 p/Share
|
Feb 11
2021 |
|
KROS
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect | 11,561 Reduced 0.17% |
$755,165
$65.32 p/Share
|
Feb 11
2021 |
|
KROS
|
Claudia Ordonez
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 100.0% |
$65,370
$65.37 p/Share
|
Feb 11
2021 |
|
KROS
|
Jennifer Lachey
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,300 Reduced 15.92% |
$346,832
$65.44 p/Share
|
Feb 11
2021 |
|
ORGO
|
Gary S. Gillheeney
President and CEO |
SELL
Open market or private sale
|
Direct | 69,127 Reduced 14.22% |
$955,335
$13.82 p/Share
|
Feb 11
2021 |
|
ORGO
|
Glenn H Nussdorf
Director |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 0.29% |
$650,000
$3.25 p/Share
|
Feb 11
2021 |
|
ORGO
|
Alan A. Ades
Director |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 0.29% |
$650,000
$3.25 p/Share
|
Feb 11
2021 |
|
FLWS
|
Christopher G Mccann
Director |
SELL
Open market or private sale
|
Direct | 17,850 Reduced 4.09% |
$572,628
$32.08 p/Share
|
Feb 11
2021 |
|
SCVL
|
Timothy T Baker |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.29% |
$502,500
$50.25 p/Share
|
Feb 11
2021 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,446 Reduced 1.6% |
$51,232
$35.43 p/Share
|
Feb 11
2021 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,428 Reduced 39.06% |
$50,537
$35.39 p/Share
|
Feb 11
2021 |
|
RMAX
|
Brett A Ritchie
SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 267 Reduced 1.53% |
$10,680
$40.0 p/Share
|
Feb 11
2021 |
|
ONEW
|
John Troiano |
SELL
Open market or private sale
|
Indirect | 19,705 Reduced 5.09% |
$699,922
$35.52 p/Share
|
Feb 11
2021 |
|
EVER
|
Jayme Mendal
CEO and President |
SELL
Open market or private sale
|
Direct | 665 Reduced 0.34% |
$33,789
$50.81 p/Share
|
Feb 11
2021 |
|
VYGR
|
Andre Turenne
President & CEO |
SELL
Open market or private sale
|
Direct | 7,977 Reduced 5.1% |
$60,226
$7.55 p/Share
|
Feb 11
2021 |
|
VYGR
|
Allison Dorval
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,186 Reduced 6.49% |
$24,054
$7.55 p/Share
|
Feb 11
2021 |
|
VYGR
|
Robert W. Hesslein
Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct | 3,186 Reduced 6.06% |
$24,054
$7.55 p/Share
|
Feb 11
2021 |
|
VYGR
|
Omar Khwaja
Officer |
SELL
Open market or private sale
|
Direct | 3,475 Reduced 6.15% |
$26,236
$7.55 p/Share
|
Feb 11
2021 |
|
IMMR
|
Michael Rudolf Okada
General Counsel |
SELL
Open market or private sale
|
Direct | 2,400 Reduced 15.72% |
$36,744
$15.31 p/Share
|
Feb 11
2021 |
|
AVYA
|
James M Chirico
President & CEO |
SELL
Open market or private sale
|
Direct | 304,469 Reduced 26.94% |
$10,090,102
$33.14 p/Share
|
Feb 11
2021 |
|
GHL
|
David Wyles
President |
SELL
Open market or private sale
|
Direct | 62 Reduced 0.1% |
$930
$15.0 p/Share
|
Feb 11
2021 |
|
GHL
|
Kevin M Costantino
President |
SELL
Open market or private sale
|
Direct | 83,770 Reduced 79.47% |
$1,238,958
$14.79 p/Share
|
Feb 11
2021 |
|
BCV
|
Mario J Gabelli
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.4% |
$17,640
$35.28 p/Share
|
Feb 11
2021 |
|
PXLW
|
Todd Debonis
President and CEO |
SELL
Open market or private sale
|
Direct | 196,137 Reduced 14.97% |
$727,668
$3.71 p/Share
|
Feb 11
2021 |
|
LOV
|
Canaan Viii LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.29% |
$77,700
$7.77 p/Share
|
Feb 11
2021 |
|
RUBY
|
David R Epstein
Director |
SELL
Open market or private sale
|
Direct | 26,704 Reduced 0.57% |
$398,691
$14.93 p/Share
|
Feb 11
2021 |
|
BCEL
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 2.67% |
$189,300
$18.93 p/Share
|
Feb 11
2021 |
|
MNPR
|
Tactic Pharma LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 42.86% |
$1,896,250
$15.17 p/Share
|
Feb 11
2021 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 11,849 Reduced 0.06% |
$2,886,535
$243.61 p/Share
|
Feb 11
2021 |
|
ENVA
|
James A Gray |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 4.41% |
$86,100
$28.7 p/Share
|
Feb 11
2021 |
|
KPTI
|
Tanya Lewis
EVP, Chief Reg. Affairs |
SELL
Open market or private sale
|
Direct | 2,046 Reduced 33.06% |
$31,754
$15.52 p/Share
|
Feb 11
2021 |
|
KPTI
|
Jatin Shah
EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,748 Reduced 3.5% |
$27,129
$15.52 p/Share
|
Feb 11
2021 |
|
KPTI
|
Ran Frenkel
EVP, Chief Dev. Officer |
SELL
Open market or private sale
|
Direct | 2,046 Reduced 4.94% |
$31,754
$15.52 p/Share
|
Feb 11
2021 |
|
KPTI
|
Michael Mason
EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 2,858 Reduced 35.07% |
$44,356
$15.52 p/Share
|
Feb 11
2021 |
|
KPTI
|
Sharon Shacham
Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect | 6,601 Reduced 1.16% |
$102,448
$15.52 p/Share
|
Feb 11
2021 |